Predictors of time in target glucose range in real‐world users of the <scp>MiniMed 780G</scp> system-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of time in target glucose range in real‐world users of the MiniMed 780G system

Published:2022-08 Issue:11 Volume:24 Page:2212-2221
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Castañeda Javier¹^ORCID,Mathieu Chantal²^ORCID,Aanstoot Henk‐Jan³,Arrieta Arcelia¹,Da Silva Julien⁴,Shin John⁵,Cohen Ohad⁴^ORCID

Affiliation:

1. Medtronic Bakken Research Center Maastricht The Netherlands

2. Clinical and Experimental Endocrinology KU Leuven Leuven Belgium

3. Diabeter, Center for Diabetes Care and Research Rotterdam The Netherlands

4. Medtronic International Trading Sàrl Tolochenaz Switzerland

5. Medtronic Northridge California USA

Funder

Medtronic

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14807

Reference28 articles.

1. Real-world Performance of the MiniMed™ 780G System: First Report of Outcomes from 4’120 Users

2. Correction to: New closed-loop insulin systems

3. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review

4. Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes

5. Real‐world performance of the MiniMed™ 670G system in Europe

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort;Diabetes Research and Clinical Practice;2024-10

2. Generating real‐world evidence on diabetes technology using the CareLink Personal data management system;Diabetes, Obesity and Metabolism;2024-09-04

3. MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert Recommendations;Diabetes Technology & Therapeutics;2024-08-22

4. Real-World Evidence of Omnipod^® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes;Diabetes Technology & Therapeutics;2024-08-01

5. Postprandial Glucose Control With Different Hybrid Closed-Loop Systems According to Type of Meal in Adults With Type 1 Diabetes;Journal of Diabetes Science and Technology;2024-06-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3